Deal Questions

Spar with your thesis before the market does

Maple Manufacturing Co. · active scenario Base

ValuationExitRevenueDownsideStructureDebtMarginsCapex
Valuationopen

Why is the entry multiple 4.2x on LTM EBITDA?

Entry pricing anchors every return. Banks and sellers will challenge this first.

Exitopen

Exit multiple (4.5x) vs entry (4.2x) — what justifies the delta?

Multiple expansion needs a story (scale, mix, multiple arbitrage).

Revenueopen

Base Y1 growth is 3.0% vs recent history 4.7%. What's the driver?

Searchers often overstate growth. Tie it to contracts, capacity, or pricing evidence.

Downsideopen

Would you still do the deal at downside (IRR 16.3%, MOIC 2.1x)?

If downside breaks your hurdle, the structure or price needs work.

Structureopen

Entry leverage is 2.6x. Is that normal for this sector and size?

Lenders price risk off leverage and DSCR. Over-leverage kills flexibility.

Debtopen

Min DSCR in base is 1.83x. What's the covenant buffer?

Cash sweep and amort plans only work if coverage holds under stress.

Structureopen

Why is the seller financing 16% of sources as a seller note?

Seller financing and rollover align incentives and bridge valuation gaps.

Revenueopen

Upside IRR 36.9% vs base 28.2% — what has to go right for upside?

Upside without named drivers is hope, not a plan.

Marginsopen

Base margin goes from 18.4% (LTM) to 19.5% at exit. What delivers the expansion?

Margin improvement needs pricing power, mix shift, or cost-out — name which, with evidence.

Capexopen

Is planned capex enough to sustain the revenue and margin plan?

Buyers and lenders discount EBITDA that is propped up by deferred maintenance capex.

Structureopen

Equity is 41% of total uses. Will senior lenders accept that cushion?

Most SMB/LBO lenders want 30-50% equity+quasi-equity below them; thin equity gets repriced or rejected.

Debtopen

Cash sweep is 50% of excess FCF. What's the intended use of retained cash?

Idle cash earns nothing in this model; deleveraging is usually the highest-return use of FCF early in the hold.

Valuationanswered

Transaction fees at 3.0% of EV are within the usual 2-4% band.

Fees come straight out of the equity check; overstated fees quietly depress every return metric.

Exitopen

Why exit in year 5? What buyer would pay the exit multiple then?

Exit timing must match maturity of the thesis and buyer landscape.